Bumrungrad Hospital Public Company Stock Forecast for 2023 - 2025 - 2030
Updated on 03/29/2024
Bumrungrad Hospital Public Company Stock Forecast and Price Target
Bumrungrad Hospital Public Company has an average price target of ฿281.00 recently offered by five notable experts for 2024, which would represent a potential upside of approximately 23.25% from the last closing price in March, 2024 if reached. This potential increase is based on a high estimate of ฿313.00 and a low estimate of ฿245.00. If you're interested in BH stock, it's important to compare it to other companies in the industry.
23.25% Upside
Bumrungrad Hospital Public Company Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Bumrungrad Hospital Public Company's Price has decreased from ฿64.86 to ฿0.00 – a 100.00% drop. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach ฿394.74 – an increase of 100.00%. Over the next seven years, experts anticipate that Fair Value growth for Bumrungrad Hospital Public Company will be 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BDMS Stock Forecast | Bangkok Dusit Medical Services... | Buy |
18
|
฿29.25 | Buy/Sell | ฿33.89 | 19.66% |
IHH Stock Forecast | IHH Healthcare Berhad | Outperform |
18
|
RM6.08 | Buy/Sell | RM7.00 | 17.93% |
APOLLOHOSP Stock Forecast | Apollo Hospitals Enterprise | Outperform |
18
|
Rp6.20k | Buy/Sell | Rp6.91k | 15.89% |
RHC Stock Forecast | Ramsay Health Care | Hold |
18
|
$55.15 | Buy/Sell | $56.32 | 3.35% |
600196 Stock Forecast | Shanghai Fosun Pharmaceutical ... | Outperform |
16
|
¥24.76 | Buy/Sell | ¥33.57 | 25.77% |
Bumrungrad Hospital Public Company Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Revenue for Bumrungrad Hospital Public Company has grown by 105.36%, going from ฿12.44B to ฿25.55B. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach ฿26.43B – an increase of 3.47%. Over the next seven years, experts anticipate that Revenue growth for Bumrungrad Hospital Public Company will be 2.39%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
FORTIS Stock Forecast | Fortis Healthcare | Outperform |
10
|
Rp412.70 | Buy/Sell | Rp401.86 | 18.12% |
NH Stock Forecast | Narayana Hrudayalaya | Outperform |
16
|
Rp1.28k | Buy/Sell | Rp1.20k | 12.45% |
MIKA Stock Forecast | PT Mitra Keluarga Karyasehat T... | Outperform |
16
|
Rp2.57k | Buy/Sell | Rp3.00k | 16.73% |
Bumrungrad Hospital Public Company Dividend per Share Forecast for 2023 - 2025 - 2030
Bumrungrad Hospital Public Company's Dividend per Share has grown in the last three years, jumping from ฿3.20 to ฿4.50 – an increase of 40.63%. In the next year, analysts predict that Dividend per Share will reach ฿4.72 – an increase of 4.89%. For the next seven years, the forecast is for Dividend per Share to grow by 11.61%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
SILO Stock Forecast | PT Siloam International Hospit... | Buy |
10
|
Rp2.21k | Buy/Sell | Rp2.61k | 31.22% |
KPJ Stock Forecast | KPJ Healthcare Berhad | Outperform |
17
|
RM1.74 | Buy/Sell | RM1.54 | 5.75% |
BCH Stock Forecast | Bangkok Chain Hospital Public ... | Buy |
18
|
฿21.80 | Buy/Sell | ฿27.85 | 10.09% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BSL Stock Forecast | Raffles Medical Group Ltd | Outperform |
18
|
$1.05 | Buy/Sell | $1.39 | 9.52% |
SVH Stock Forecast | Samitivej Public Company | - |
16
|
฿430.00 | Buy/Sell | ฿0.00 | -100.00% |
RAM Stock Forecast | Ramkhamhaeng Hospital Public C... | Underperform |
16
|
฿32.00 | Buy/Sell | ฿49.25 | 20.31% |
Bumrungrad Hospital Public Company EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Bumrungrad Hospital Public Company's EBITDA has grown, increasing from ฿2.39B to ฿9.41B – an increase of 294.05%. For next year, the 17 analysts predict EBITDA of ฿9.69B, which would mean an increase of 2.99%. Over the next seven years, the pros' prediction is EBITDAof ฿10.27B, which would mean a seven-year growth forecast of 9.15%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
A50 Stock Forecast | Thomson Medical Group | Buy |
4
|
$0.05 | Buy/Sell | $0.00 | 60.00% |
CHG Stock Forecast | Chularat Hospital Public Compa... | Outperform |
18
|
฿2.94 | Buy/Sell | ฿3.38 | 17.35% |
SRAJ Stock Forecast | PT Sejahteraraya Anugrahjaya T... | - |
10
|
Rp1.21k | Buy/Sell | Rp0.00 | -100.00% |
Bumrungrad Hospital Public Company EBIT Forecast for 2023 - 2025 - 2030
Bumrungrad Hospital Public Company's EBIT has increased by 519.14% In the last three years, going from ฿1.37B to ฿8.47B. The next year, 17 experts forecast that Bumrungrad Hospital Public Company's EBIT will decrease by 0.55%, reaching ฿8.43B. For the next seven years, the forecast is for EBIT to grow by 492.90%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
1515 Stock Forecast | China Resources Medical Holdin... | Outperform |
18
|
HK$3.82 | Buy/Sell | HK$7.92 | 69.37% |
VIBHA Stock Forecast | Vibhavadi Medical Center Publi... | Buy |
18
|
฿1.94 | Buy/Sell | ฿2.88 | 64.95% |
SKR Stock Forecast | Sikarin Public Company | - |
18
|
฿10.10 | Buy/Sell | ฿0.98 | -100.00% |
Bumrungrad Hospital Public Company EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Bumrungrad Hospital Public Company's EPS has decreased from ฿1.39 to ฿0.00 – a 100.00% drop. In the coming year, analysts are expecting an increase in EPS, predicting it will reach ฿8.46 – an increase of 100.00%. Over the next seven years, experts anticipate that EPS growth for Bumrungrad Hospital Public Company will be 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
HCG Stock Forecast | HealthCare Global Enterprises | Outperform |
9
|
334.15 | Buy/Sell | 414.64 | 29.28% |
SAME Stock Forecast | PT Sarana Meditama Metropolita... | - |
13
|
Rp304.00 | Buy/Sell | Rp730.00 | -100.00% |
1526 Stock Forecast | Rici Healthcare Holdings | - |
8
|
HK$1.14 | Buy/Sell | HK$2.21 | -100.00% |